# Benfotiamine Versus Vitamin B1-6-12 for Diabetic Peripheral Neuropathy

> **NCT07708233** · PHASE4 · RECRUITING · sponsor: **Thammasat University** · enrollment: 66 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy (DPN)

## Interventions

- **DRUG:** Benfotiamine
- **DRUG:** Vitamin B1-6-12

## Key facts

- **NCT ID:** NCT07708233
- **Lead sponsor:** Thammasat University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708233, "Benfotiamine Versus Vitamin B1-6-12 for Diabetic Peripheral Neuropathy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*